Incyte Corporation: Why Jakafi Is No Longer The Real Story Here (NASDAQ:INCY)

seekingalpha.com · 2026-09-02

Incyte is transitioning from a Jakafi-centric model to a diversified, multi-franchise biotech with several late-stage pipeline assets. See why INCY stock is a Buy.

Read the full story at seekingalpha.com →